Form 4: Third Harmonic Bio Executive Conner Exercises Options and Sells Shares

Sentiment:

SEC Form 4


Edward R. Conner, Chief Medical Officer of Third Harmonic Bio, exercised stock options and sold shares on October 28, 2024, according to a Form 4 filing.

Summary

  • On October 28, 2024, Edward R. Conner, the Chief Medical Officer of Third Harmonic Bio, exercised options to acquire 2,673 shares of common stock at a price of $4.20 per share.
  • Concurrently, Conner sold 2,673 shares at $15.00 per share.
  • These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 27, 2024.
  • Following these transactions, Conner directly owns 371,035 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports transactions by an officer. The transactions are part of a pre-arranged trading plan, which mitigates concerns about insider information.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and potential future performance of the company.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders as they provide insight into management's actions, but the pre-arranged trading plan suggests limited informational value.

Key Dates

DateDescription
2023-06-0625% of the total shares vest.
2024-03-27Rule 10b5-1 trading plan adopted.
2024-10-28Exercise of stock options and sale of shares.
2032-07-27Expiration date of employee option grant.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.